News

Aptamer Group, a developer of next-generation synthetic binders delivering innovation to the life science industry, says a ...
GAL-101 well tolerated; excellent safety and pharmacokinetic profile strongly supports oral administration; Next arms of ...
In the modern age of medical marvels, it’s easy to believe that science can solve almost any health problem. From vaccines to ...